Erste Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Erste Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,000	Closed	-$513K	–	532
2021 Q2	$513K	Hold	20,000	–	–	0.01%	407
2021 Q1	$321K	Hold	20,000	–	–	0.01%	422
2020 Q4	$390K	Buy	+20,000	New	+$358K	0.01%	410

Erste Asset Management's TBIO Position: Q3 2021 in Review

Erste Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 20,000 shares — an estimated $513K sold.

Erste Asset Management first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $513K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Erste Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Erste Asset Management sold 20,000 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $513K.
Erste Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
Erste Asset Management's Translate Bio, Inc. Common Stock position peaked at $513K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Erste Asset Management's 13F filing for Q3 2021, filed 25 Nov 2024.